Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment

Although cystic fibrosis (CF) is an irreversible genetic disease, advances in treatment have increased the life expectancy of CF patients. Upper airway involvement, which is mainly due to pathological changes in the paranasal sinuses, is prevalent in CF patients, although many are only mildly sympto...

Full description

Bibliographic Details
Main Authors: Suzie Hyeona Kang, Paulo de Tarso Roth Dalcin, Otavio Bejzman Piltcher, Raphaella de Oliveira Migliavacca
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2015-02-01
Series:Jornal Brasileiro de Pneumologia
Subjects:
Online Access:http://www.scielo.br/pdf/jbpneu/v41n1/pt_1806-3713-jbpneu-41-01-00065.pdf
_version_ 1819003242979262464
author Suzie Hyeona Kang
Paulo de Tarso Roth Dalcin
Otavio Bejzman Piltcher
Raphaella de Oliveira Migliavacca
author_facet Suzie Hyeona Kang
Paulo de Tarso Roth Dalcin
Otavio Bejzman Piltcher
Raphaella de Oliveira Migliavacca
author_sort Suzie Hyeona Kang
collection DOAJ
description Although cystic fibrosis (CF) is an irreversible genetic disease, advances in treatment have increased the life expectancy of CF patients. Upper airway involvement, which is mainly due to pathological changes in the paranasal sinuses, is prevalent in CF patients, although many are only mildly symptomatic (with few symptoms). The objective of this literature review was to discuss the pathophysiology and current therapeutic management of chronic rhinosinusitis (CRS) in CF patients. The review was based on current evidence, which was classified in accordance with the Oxford Centre for Evidence-Based Medicine criteria. When symptomatic, CRS with nasal polyps can affect quality of life and can lead to pulmonary exacerbations, given that the paranasal sinuses can be colonized with pathogenic bacteria, especially Pseudomonas aeruginosa. Infection with P. aeruginosa plays a crucial role in morbidity and mortality after lung transplantation in CF patients. Although clinical treatment of the upper airways is recommended as initial management, this recommendation is often extrapolated from studies of CRS in the general population. When sinonasal disease is refractory to noninvasive therapy, surgery is indicated. Further studies are needed in order to gain a better understanding of upper airway involvement and improve the management of CRS in CF patients, with the objective of preserving lung function and avoiding unnecessary invasive procedures.
first_indexed 2024-12-20T23:17:54Z
format Article
id doaj.art-ab7f92f187e5423a9a7fdc7e5a9df234
institution Directory Open Access Journal
issn 1806-3756
language English
last_indexed 2024-12-20T23:17:54Z
publishDate 2015-02-01
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format Article
series Jornal Brasileiro de Pneumologia
spelling doaj.art-ab7f92f187e5423a9a7fdc7e5a9df2342022-12-21T19:23:35ZengSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia1806-37562015-02-01411657610.1590/s1806-37132015000100009Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatmentSuzie Hyeona KangPaulo de Tarso Roth DalcinOtavio Bejzman PiltcherRaphaella de Oliveira MigliavaccaAlthough cystic fibrosis (CF) is an irreversible genetic disease, advances in treatment have increased the life expectancy of CF patients. Upper airway involvement, which is mainly due to pathological changes in the paranasal sinuses, is prevalent in CF patients, although many are only mildly symptomatic (with few symptoms). The objective of this literature review was to discuss the pathophysiology and current therapeutic management of chronic rhinosinusitis (CRS) in CF patients. The review was based on current evidence, which was classified in accordance with the Oxford Centre for Evidence-Based Medicine criteria. When symptomatic, CRS with nasal polyps can affect quality of life and can lead to pulmonary exacerbations, given that the paranasal sinuses can be colonized with pathogenic bacteria, especially Pseudomonas aeruginosa. Infection with P. aeruginosa plays a crucial role in morbidity and mortality after lung transplantation in CF patients. Although clinical treatment of the upper airways is recommended as initial management, this recommendation is often extrapolated from studies of CRS in the general population. When sinonasal disease is refractory to noninvasive therapy, surgery is indicated. Further studies are needed in order to gain a better understanding of upper airway involvement and improve the management of CRS in CF patients, with the objective of preserving lung function and avoiding unnecessary invasive procedures.http://www.scielo.br/pdf/jbpneu/v41n1/pt_1806-3713-jbpneu-41-01-00065.pdfNose diseasesCystic fibrosisNasal polypsParanasal sinusesSinusitis
spellingShingle Suzie Hyeona Kang
Paulo de Tarso Roth Dalcin
Otavio Bejzman Piltcher
Raphaella de Oliveira Migliavacca
Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
Jornal Brasileiro de Pneumologia
Nose diseases
Cystic fibrosis
Nasal polyps
Paranasal sinuses
Sinusitis
title Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
title_full Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
title_fullStr Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
title_full_unstemmed Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
title_short Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
title_sort chronic rhinosinusitis and nasal polyposis in cystic fibrosis update on diagnosis and treatment
topic Nose diseases
Cystic fibrosis
Nasal polyps
Paranasal sinuses
Sinusitis
url http://www.scielo.br/pdf/jbpneu/v41n1/pt_1806-3713-jbpneu-41-01-00065.pdf
work_keys_str_mv AT suziehyeonakang chronicrhinosinusitisandnasalpolyposisincysticfibrosisupdateondiagnosisandtreatment
AT paulodetarsorothdalcin chronicrhinosinusitisandnasalpolyposisincysticfibrosisupdateondiagnosisandtreatment
AT otaviobejzmanpiltcher chronicrhinosinusitisandnasalpolyposisincysticfibrosisupdateondiagnosisandtreatment
AT raphaelladeoliveiramigliavacca chronicrhinosinusitisandnasalpolyposisincysticfibrosisupdateondiagnosisandtreatment